Laurus Labs Ltd Share Price – NSE  / BSE

Pharmaceuticals, Small Cap

Laurus Labs Ltd gained for a fifth straight session today. The stock is quoting at Rs 1280.4, up 1.07% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is down around 1.22% on the day, quoting at 23526.15. The Sensex is at 74972.87, down 1.37%. Laurus Labs Ltd has risen around 17.71% in last one month.

Meanwhile, Nifty Pharma index of which Laurus Labs Ltd is a constituent, has risen around 8.59% in last one month and is currently quoting at 24170.45, down 0.71% on the day. The volume in the stock stood at 13.65 lakh shares today, compared to the daily average of 22.25 lakh shares in last one month.

The benchmark May futures contract for the stock is quoting at Rs 1284.3, up 1.22% on the day. Laurus Labs Ltd is up 115.1% in last one year as compared to a 4.28% drop in NIFTY and a 12.36% drop in the Nifty Pharma index.

The PE of the stock is 92.31 based on TTM earnings ending March 26.

Powered by Capital Market - Live News

Laurus Labs Ltd is up for a third straight session in a row. The stock is quoting at Rs 1227.6, up 1.75% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is down around 0.64% on the day, quoting at 24170.45. The Sensex is at 77285.81, down 0.72%. Laurus Labs Ltd has added around 13.28% in last one month.

Meanwhile, Nifty Pharma index of which Laurus Labs Ltd is a constituent, has added around 9.03% in last one month and is currently quoting at 24135.5, down 0.01% on the day. The volume in the stock stood at 14.75 lakh shares today, compared to the daily average of 21.07 lakh shares in last one month.

The benchmark May futures contract for the stock is quoting at Rs 1230.1, up 1.49% on the day. Laurus Labs Ltd is up 108.49% in last one year as compared to a 0.68% gain in NIFTY and a 14.53% gain in the Nifty Pharma index.

The PE of the stock is 87.93 based on TTM earnings ending March 26.

Powered by Capital Market - Live News

Net profit of Laurus Labs rose 19.46% to Rs 279.14 crore in the quarter ended March 2026 as against Rs 233.67 crore during the previous quarter ended March 2025. Sales rose 5.31% to Rs 1811.57 crore in the quarter ended March 2026 as against Rs 1720.30 crore during the previous quarter ended March 2025.

For the full year,net profit rose 148.04% to Rs 888.79 crore in the year ended March 2026 as against Rs 358.32 crore during the previous year ended March 2025. Sales rose 22.67% to Rs 6812.90 crore in the year ended March 2026 as against Rs 5553.96 crore during the previous year ended March 2025.

Powered by Capital Market - Live News

Laurus Labs announced that the 21th Annual General Meeting(AGM) of the company will be held on 2 July 2026.